Companies · AI / ML

VitruvianMD

Africa · AI / ML

Diligence memoA one-page analyst read on VitruvianMD — recommendation, valuation, rhythm, risks.
Total raised · real
1
Rounds
Latest step-up
Top 39%
Sector rank · raised
Pre-Seed
Latest stage · inferred · Fri Aug 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

VitruvianMD: limited disclosed financing to assess.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the ai/ml sector profile.

Leadership

No named principal in this company's public records yet — see all operators below.

1 Investor
Where it sits in AI / ML

VitruvianMD is one of 2067 AI / ML companies tracked from Africa. By capital raised it ranks mid-pack (ahead of 62% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

OLYMPUS DIGITAL CAMERA SA e-health VitruvianMD raises 8-figure ZAR funding round 0 By Tom Jackson on August 20, 2021 News , Southern Africa South African e-health startup VitruvianMD has raised an eight-figure ZAR – so at least ZAR10 million (US$659,000) – funding round in order to scale its tech and launch more pilots. Founded last year, VitruvianMD combines biomedical engineering and state-of-the-art artificial intelligence (AI) to deliver affordable, high-accuracy diagnostic tools for medical laboratories, with a particular focus on servicing emerging markets.

OLYMPUS DIGITAL CAMERA SA e-health VitruvianMD raises 8-figure ZAR funding round 0 By Tom Jackson on August 20, 2021 News , Southern Africa South African e-health startup VitruvianMD has raised an eight-figure ZAR – so at least ZAR10 million (US$659,000) – funding round in order to scale its tech and launch more pilots. Founded last year, VitruvianMD combines biomedical engineering and state-of-the-art artificial intelligence (AI) to deliver affordable, high-accuracy diagnostic tools for medical laboratories, with a particular focus on servicing emerging markets.

ai/ml

As reported in public records reported — not modeled.

ZA
Jurisdiction
1
Investors (latest)
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

No round amounts on record to chart.

Financing ladder & sequence gaps
Pre-Seed · 2021

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
Base estimate est.
Conservative case
Upside case
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seeda round under $1.0M). Valuation is modeled from stage benchmarks scaled by the ai/ml sector profile. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Financing rhythm
Avg between rounds
Capital velocity
On record since
First round
0
Rounds on file
How it compares to the market

Benchmarked against 2067 companies in AI / ML. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages)
This company
Sector median$4.7M
Latest round — vs other Pre-Seed rounds in sector (real $, this stage)
This company
Sector median$350K
Modeled value — vs sector median (estimate, all stages)
This company
Sector median$27.9M

Raised more than 62% of sector peers (real $). Modeled value above 62% of peers (estimate).

Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed2021-08-2045%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed2021-08-20
    • First recorded raise — entered as Pre-Seed.
    • 1 investor on this round.
Intelligence
Modeled next raise
Modeled next size est.
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Registry & provenance

VitruvianMD is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
ZA
Jurisdiction
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
AccordAI / MLsame sector
AcelyAI / MLsame sector
AedilicAI / MLsame sector
AemonAI / MLsame sector
Affogato AIAI / MLsame sector
AftercareAI / MLsame sector
Agentic LabsAI / MLsame sector
Ai AibaAI / MLsame sector
Investors

Public records name issuer insiders, not the funds in a round — these investor links come from corroborating sources.

FirmRoundConfidence
Verge Healthtech FundPre-Seed55%
Frequently asked
What funding stage is VitruvianMD at?
VitruvianMD's latest modeled financing stage is Pre-Seed. Its most recent recorded round closed around Fri Aug 20.
What does VitruvianMD do and where is it based?
VitruvianMD operates in the AI / ML sector, based in Africa. OLYMPUS DIGITAL CAMERA SA e-health VitruvianMD raises 8-figure ZAR funding round 0 By Tom Jackson on August 20, 2021 News , Southern Africa South African e-health startup VitruvianMD has raised an eight-figure ZAR – so at least ZAR10 million (US$659,000) – funding round in order to scale its tech and launch more pilots. Founded last year, VitruvianMD combines biomedical engineering and state-of-the-art artificial intelligence (AI) to deliver affordable, high-accuracy diagnostic tools for medical laboratories, with a particular focus on servicing emerging markets.
Explore related

See where VitruvianMD sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at VitruvianMD, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.